Search clinical trials for: metastatic Castration-Resistant Prostate Cancer (mCRPC)
Total 89379 results
-
POINT Biopharma, a wholly owned subsidiary of Eli...Eli Lilly and CompanyRecruitingProstate Cancer | Biochemically Recurrent Prostate Carcinoma | Metastatic Castration-resistant Prostate CancerCanada
-
Lantheus Medical ImagingPOINT BiopharmaAvailableCastration-Resistant Prostatic CancerUnited States
-
Tianjin Medical University Second HospitalThe Second Hospital of Hebei Medical University; Tianjin Medical University... and other collaboratorsCompleted
-
PfizerAstellas Pharma IncActive, not recruitingmCRPCChina, Finland, Spain, United States, Hungary, Israel, Belgium, Korea, Republic of, France, Canada, Czechia, Australia, Japan, Brazil, Germany, Argentina, New Zealand, United Kingdom, Norway, South Africa, Poland, Portugal, Chile, Italy, Pe... and more
-
Radboud University Medical CenterVGZ health insurance (NL); Paul Speth Foundation (NL); Radboud Oncology Fund...RecruitingMetastatic Prostate CancerNetherlands
-
MANA RBMBayer; Tulane University; Barbara Ann Karmanos Cancer Institute; Carolina Urologic...TerminatedMetastatic Castration-resistant Prostate CancerUnited States
-
BayerRecruitingAdvanced Metastatic Castration-resistant Prostate Cancer | Prostate Specific Membrane Antigen (PSMA) ExpressionCanada, United Kingdom, Belgium
-
Impact Therapeutics, Inc.Not yet recruitingmCRPCAustralia, United States, China
-
Yinghao SunNot yet recruitingCastration-Resistant Prostatic Cancer
-
AstraZenecaCompleted
-
Istituto Scientifico Romagnolo per lo Studio e...RecruitingProstate-specific Membrane Antigen | mCRPC or Advanced/Metastatic Solid TumorsItaly
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityAstraZenecaRecruitingProstate Cancer | Prostate Carcinoma | Metastatic Castration-resistant Prostate CancerChina
-
Jiangxi Qingfeng Pharmaceutical Co. Ltd.UnknownMetastatic Castration Resistant Prostate Cancer
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...CompletedMetastatic Castration-resistant Prostate CancerChina
-
Fudan UniversityUnknownProstate Cancer MetastaticChina
-
Karolinska InstitutetThe Swedish Research Council; AstraZeneca; Janssen Pharmaceutica N.V., Belgium; Kom Op Tegen Kanker and other collaboratorsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Sweden, Belgium, Switzerland, Norway
-
Peking Union Medical College HospitalRecruitingMetastatic Castration-resistant Prostate CancerChina
-
University Health Network, TorontoBayerActive, not recruitingMetastatic Prostate CancerCanada
-
University of PennsylvaniaProstate Cancer FoundationRecruiting
-
BayerCompletedProstatic Neoplasms, Castration-ResistantGermany
-
Zenith EpigeneticsEnrolling by invitation
-
SCRI Development Innovations, LLCNovartisWithdrawnAdvanced Prostate CancerUnited States
-
Xinhua Hospital, Shanghai Jiao Tong University...UnknownMetastatic Castration-resistant Prostate Cancer
-
Sun Yat-sen UniversityNot yet recruitingMetastatic Prostate CancerChina
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States, Italy, Spain, Belgium, Canada, France, Korea, Republic of, United Kingdom, Brazil, Czechia, Turkey, Australia, Chile, Germany, Japan, Netherlands, Slovakia
-
Eli Lilly and CompanyActive, not recruitingProstate CancerNetherlands, United States, China, Australia, Japan, Spain, Korea, Republic of, Denmark, Germany, France, Romania
-
Innocrin PharmaceuticalProstate Cancer Foundation; Prostate Cancer Clinical Trials ConsortiumCompleted
-
SpectronRXJanssen Research & Development, LLC; Invicro; Tomopath Inc.TerminatedMetastatic Disease | Castration-Resistant Prostatic CancerUnited States
-
British Columbia Cancer AgencyCompletedMetastatic Castration-Resistant Prostate CancerCanada
-
Zenith EpigeneticsAstellas Pharma Inc; Newsoara Biopharma Co., Ltd.RecruitingMetastatic Castration-Resistant Prostate CancerUnited States, China
-
Radboud University Medical CenterBristol-Myers SquibbActive, not recruitingProstatic Neoplasms, Castration-ResistantNetherlands
-
Rahul AggarwalNovartisCompletedProstate CancerUnited States
-
Corvus Pharmaceuticals, Inc.Genentech, Inc.CompletedRenal Cell Cancer | Metastatic Castration Resistant Prostate CancerUnited States, Canada, Australia
-
PfizerIn Expanded Access, treating physicians are the SponsorsAvailableMetastatic Castration-Resistant Prostate Cancer
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Epizyme, Inc.; PfizerActive, not recruitingMetastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Janssen Research & Development, LLCRecruitingProstatic NeoplasmsUnited States, France, Spain, Netherlands
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingMetastatic Castration-resistant Prostate CancerChina
-
Innocrin PharmaceuticalNational Cancer Institute (NCI)Completed
-
Herlev and Gentofte HospitalBristol-Myers SquibbRecruitingProstate Cancer Metastatic | Metastatic Castration-resistant Prostate Cancer | Castrate Resistant Prostate Cancer | Prostate Cancer Stage IVDenmark
-
Dana-Farber Cancer InstituteEli Lilly and Company; Genentech, Inc.Active, not recruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Centro Nacional de Investigaciones Oncologicas...Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina... and other collaboratorsCompletedProstate Cancer
-
Janssen Research & Development, LLCActive, not recruitingNeoplasmsCanada, Israel, Spain
-
Arvinas Androgen Receptor, Inc.Active, not recruitingProstate Cancer MetastaticUnited States
-
University of California, San FranciscoAmerican Association for Cancer ResearchCompleted
-
BayerCompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)United States
-
Regeneron PharmaceuticalsRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
BayerCompletedMetastatic Castration Resistant Prostate Cancer (mCRPC)United States
-
Jiangsu HengRui Medicine Co., Ltd.CompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)China
-
Suzhou Kintor Pharmaceutical Inc,CompletedMetastatic Castrate Resistant Prostate Cancer (mCRPC)United States